Cambrian Bio is a clinical-stage drug development company building the medicines that will modernize healthcare in the 21st century. Our focus lies in building therapeutics to treat and prevent today’s most debilitating chronic diseases, with programs targeting critical metabolic sensing functions that decline with age, including AMPK and mTOR.
| Website | http://www.cambrianbio.com |
| Revenue | $5 million |
| Employees | 30 (20 on RocketReach) |
| Founded | 2019 |
| Phone | +1 516-962-3186 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+18 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Drug Development, Biotechnology, Therapeutics, Drug Discovery, Clinical Stage, Pharmaceutical, Disease Prevention, Biopharmaceutical, Clinical Trials, Pharmaceutical Research, Healthspan, Biomedical, Modern Healthcare, Life Sciences, New Drugs, Healthcare Innovation, Scientific Research |
| Competitors | Amgen, Novozymes, Codexis, Inc., Pivot Bio, LanzaTech, Seres Therapeutics, Geno, Zymergen, Inc., Arzeda, Telesis Bio +45 more (view full list) |
Looking for a particular Cambrian Bio employee's phone or email?
Cambrian Bio Questions
The Cambrian Bio annual revenue was $5 million in 2026.
James Peyer is the Founder and CEO of Cambrian Bio.
20 people are employed at Cambrian Bio.
Cambrian Bio is based in New York, New York.
Top Cambrian Bio Employees
-
James Peyer
Founder and CEO at Cambrian Bio
New York, NY, US23 -
Margaret Kurtz
Vice President of People and Culture at Cambrian Bio
New York, NY, US25+ -
Erik Schneider
VP, Business Development and Strategy at Cambrian Bio
New York, NY, US32 -
Mark Nuttall
Chief Business Officer at Cambrian Bio
Cambridge, MA, US25 -
24
-
12
-
21
-
Wenjie Luo
Director, Strategic Development at Cambrian Bio
New York, NY, US21 -
25
-
Travis McQuiston
Director, R and D Project Management at Cambrian Bio
Charleston, SC, US4
Related Companies
